Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis
Open Access
- 7 August 2018
- journal article
- review article
- Published by Springer Nature in BMC Medicine
- Vol. 16 (1) , 1-19
Abstract
Antibiotic resistance is an urgent global problem, but reversibility is poorly understood. We examined the development and decay of bacterial resistance in community patients after antibiotic use. This was a systematic review and meta-analysis. PubMed, EMBASE and CENTRAL (from inception to May 2017) were searched, with forward and backward citation searches of the identified studies. We contacted authors whose data were unclear, and of abstract-only reports, for further information. We considered controlled or times-series studies of patients in the community who were given antibiotics and where the subsequent prevalence of resistant bacteria was measured. Two authors extracted risk of bias and data. The meta-analysis used a fixed-effects model. Of 24,492 articles screened, five controlled and 20 time-series studies (total 16,353 children and 1461 adults) were eligible. Resistance in Streptococcus pneumoniae initially increased fourfold after penicillin-class antibiotic exposure [odds ratio (OR) 4.2, 95% confidence interval (CI) 3.5–5.4], but this fell after 1 month (OR 1.7, 95% CI 1.3–2.1). After cephalosporin-class antibiotics, resistance increased (OR 2.2, 95%CI 1.7-2.9); and fell to (OR 1.6, 95% CI 1.2-2.3) at 1 month. After macrolide-class antibiotics, resistance increased (OR 3.8, 95% CI 1.9–7.6) and persisted for 1 month (OR 5.2, 95% CI 2.6–10.3) and 3 months (OR 8.1, 95% CI 4.6–14.2, from controlled studies and OR 2.3, 95% CI 0.6–9.4, from time-series studies). Resistance in Haemophilus influenzae after penicillins was not significantly increased (OR 1.3, 95% CI 0.9–1.9) initially but was at 1 month (OR 3.4, 95% CI 1.5–7.6), falling after 3 months (OR 1.0, 95% CI 0.5–2.2). Data were sparse for cephalosporins and macrolides. Resistance in Enterobacter increased post-exposure (OR 3.2, 95% CI 0.9–10.8, from controlled studies and OR 7.1, 95% CI 4.2–12, from time-series studies], but was lower after 1 month (OR 1.8, 95% CI 0.9–3.6). Resistance generally increased soon after antibiotic use. For some antibiotic classes and bacteria, it partially diminished after 1 and 3 months, but longer-term data are lacking and urgently needed. PROSPERO CRD42015025499 .Keywords
Funding Information
- National Health and Medical Research Council (1044904)
This publication has 46 references indexed in Scilit:
- A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistanceBMC Infectious Diseases, 2014
- Antibiotics for acute otitis media in children2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnographyJournal of Antimicrobial Chemotherapy, 2011
- Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical TrialPLOS Medicine, 2010
- Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysisBMJ, 2010
- A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the FutureFrontiers in Microbiology, 2010
- Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort studyBMJ, 2007
- Increased carriage of resistant non-pneumococcal α-hemolytic streptococci after antibiotic therapyThe Journal of Pediatrics, 1999
- Emergence of High-Level Trimethoprim Resistance in FecalEscherichia coliduring Oral Administration of Trimethoprim or Trimethoprim-SulfamethoxazoleNew England Journal of Medicine, 1982